NIAID Small Business Applicant Assistance Program

Posted on by

Opening soon!

The National Institute of Allergy and Infectious Diseases (NIAID) Small Business Applicant Assistance Program (AAP) Cycle 3 will open on May 13, 2024. This program cycle is intended for applicants who plan to submit their Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) grant applications for the September 5, 2024 submission deadline.

The NIAID Small Business AAP will offer support for companies planning to apply for a NIAID Phase I, Phase II/IIB, Fast Track, or Direct-to-Phase II Small Business Innovation Research STTR/ STTR Awards at no cost. NIAID encourages AAP participation from small businesses that are owned or operated by individuals who are traditionally underrepresented in biomedical sciences, such as women-owned small businesses, socially/economically disadvantaged small businesses, and companies located within Historically Under-utilized Business (HUB) Zones.

Participants in the NIAID AAP will work one-on-one with a Senior Consultant from Foresight Science & Technology, who will help you prepare your proposal with such services as Outlines and Checklist, Registration Guidance, Review and Feedback on Commercialization Plan, Research Strategy, Budget, and/or other Attachments.

To be eligible for the program, you must meet the following criteria:

The research area of interest aligns with the mission of NIAID. You can read NIAID High-Priority Areas of Interest to determine if your application fits within NIAID’s mission.
Your company intends to submit a Phase I, Phase II, Fast Track, or Direct-to-Phase II SBIR/STTR application. Completion of the 4 required registrations is strongly recommended for all applicants. If you have completed the registrations in the past, please make sure that all registrations are renewed and updated properly.
Your Phase II application must be received within the first six receipt dates following the expiration of the Phase I budget period.
Your company intends to submit an application for the September 5, 2024 grant submission deadline.
Your company must be eligible to apply for NIH SBIR/STTR grants based on the NIH Small Business Eligibility Criteria.

Participation in the AAP is limited to the first 35 qualified applicants.

The NIAID AAP is also hosting an Office Hour session on May 20, 2024, from 2-3pm EDT. During the office hour, NIAID Small Business Program staff and representatives from Foresight will be available to answer any questions applicants might have regarding the AAP including eligibility criteria, application process, available resources, how to work effectively with AAP consultants. Please register to attend this office hour if you have any NIAID AAP related questions.

For additional questions regarding the NIAID Applicant Assistance Program, please contact:

Mrs. Kelli Cardoso
Program Administrator
Foresight Science & Technology
Email: kelli.cardoso@foresightst.com

New TABA Service Available from Foresight

Posted on by

Foresight Science & Technology (Foresight), in collaboration with their consulting partners, has developed a dynamic matchmaking service to rapidly scale SBIR/STTR companies’ research and commercialization. To help alleviate time, funding, and resources that SBIR companies may not have, Foresight can be the bridge between SBIR companies and federal laboratories. Under the SBIR Technical and Business Assistance (TABA) program, SBIR companies can work with Foresight as a vendor to accomplish their commercialization objectives. With this TABA service Foresight will provide guidance to the company along the way, identifying resources and facilities, and assisting with any agreements that may be necessary to collaborate with the laboratory. This service is designed to rapidly scale SBIR research and commercialization by tapping into the vast range of resources available within federal research enterprises.

Why choose Foresight?

Foresight has a long history of both SBIR commercialization success and federal technology transfer partnerships. Existing relationships with numerous federal laboratories allow Foresight consultants to quickly identify the right partner for their SBIR clients and can effectively build new networks between the private sector and federal government that have been previously overlooked.

Foresight is seeking SBIR companies with unmet research needs that would like to take advantage of this new, exciting service. We are eager to help you rapidly scale your research and commercialization needs!

The Catalyst SBIR-STTR Summit

Posted on by

Foresight exhibited at The Catalyst Center for Business & Entrepreneurship’s SBIR-STTR Summit on February 23, 2021. This virtual event brought together innovators, creators, and entrepreneurs from all areas – commercial, government and academia. If you didn’t get the chance to stop by our virtual exhibit, Click here to learn more about Foresight’s SBIR/STTR Technical and Business Assistance (TABA) services!

2019-2020 NIH Niche Assessment Program

Posted on by

For HHS SBIR/STTR Phase I Awardees

THE APPLICATION PERIOD FOR THE 2019-2020 NIH NICHE ASSESSMENT PROGRAM IS NOW CLOSED

Additional Technical Assistance information will be available prior to Fall 2020.

The Niche Assessment Program is designed to help small businesses jump start their commercialization efforts. All active HHS (NIH, CDC, FDA) SBIR/STTR Phase I awardees and Phase I Fast-Track awardees (by grant or contract) are eligible to apply. Registration is on a first-come, first-serve basis!

The Niche Assessment Program provided by Foresight Science & Technology provides awardees with market insight and data that can be used to help strategically position their technology in the marketplace, develop their commercialization plans for their Phase II application, and be exposed to potential partners.

Technology Niche Analyses® (TNA®) are provided by Foresight for two hundred (200) HHS SBIR/STTR Phase I awardees. These analyses assess potential applications for a technology and then for one viable application, it provides an assessment of the:

Needs and concerns of end-users;
Competing technologies and competing products;
Competitive advantage of the SBIR/STTR-developed technology;
Market size and potential market share (may include national and/or global markets);
Barriers to market entry (may include but is not limited to pricing, competition, government regulations, manufacturing challenges, capital requirements, etc.);
Market drivers;
Status of market and industry trends;
Potential customers, licensees, investors, or other commercialization partners; and,
The price customers are likely to pay.

Each participant receives an in-depth report of Foresight’s findings. Oftentimes the small businesses can use this information in their commercialization plans which are part of their Phase II applications.

The analysis has three steps:

(1) In the first step, Foresight will gather the pertinent information needed from the SBIR/STTR awardee to identify feasible applications of the technology. Often times, several non-obvious uses are found, and such secondary applications may provide a path to market that is faster than the primary biomedical use.
(2) In the second step, Foresight will analyze the selected use of the technology to determine the end-user needs, current and emerging competing technologies, market dynamics, socio-economic trends and market drivers, and to quantify the market size and participant’s possible share. This second step determines the technology’s current competitive advantages and how to improve competitiveness.
(3) In the third step, Foresight will recommend a market entry strategy. This strategy includes how to market the technology to end-users, how to obtain outside partners, and also projects revenues for the technology. Likely lead customers, testing centers, suppliers, manufacturers, and/or other relevant organizations interested in participating in the downstream research as beta testers or concurrent engineering advisors will be identified.

For assistance regarding the online set-up form, please contact:
Ms. Paula Williams
Project Coordinator
Foresight Science & Technology
Telephone: (401) 273-4844, ext. 4001
Email: Paula.Williams@foresightst.com

Specific questions about TNA’s may be directed to:
Konstantin Izvolsky, PhD.
Director of Consulting and Training
Foresight Science & Technology
Telephone: (401) 273-4844, ext. 4003
Email: konstantin.izvolsky@foresightst.com

General questions about Niche Assessment Program may be directed to:
Robert Vinson
Program Manager
NIH SBIR/STTR Program
Office of Extramural Programs
Phone: (301) 435-2713
Email: sbir@od.nih.gov